; and (B) not later than 2 years after the date of enactment of the Commitment to Defeat the Virus and Keep America Healthy Act , issue final guidance with respect to the implementation of such program. (3) Report The Secretary shall make available on the public website of the Food and Drug Administration an annual report on the progress of the program under this section. . C Improving the American Drug Supply Chain 2021. Study and reporting on domestic and foreign production (a) In general The Secretary of Health and Human Services shall enter into an agreement with the National Academies of Sciences, Engineering, and Medicine (referred to in this section as the National Academies ) under which, not later than 24 months after the date of enactment of this Act, the National Academies will— (1) study the current and historical production of drugs and key ingredients thereof (including active pharmaceutical ingredients) in the United States and in foreign countries; (2) formulate recommendations for promoting increased production of drugs and key ingredients thereof (including active pharmaceutical ingredients) in the United States; and (3) in a manner that does not compromise national security or disclose trade secrets or other confidential commercial information that is subject to section 552(b)(4) of title 5, United States Code, or section 1905 of title 18, United States Code, submit a report to the Congress on— (A) the findings and conclusions of the study under paragraph (1); and (B) the recommendations under paragraph (2). (b) Study topics The study pursuant to subsection (a)(1) shall include— (1) evaluation of— (A) the extent to which production of drugs for use in the United States and key ingredients thereof (including active pharmaceutical ingredients) takes place in the United States; and (B) the extent to which such production takes place in foreign countries; (2) identification of the foreign countries in which such production takes place